bionanogenomics.com (BNGO) - Cash Funds Calculated per Share

Symbol and logo of brand Bionano Genomics (BNGO)

Patent protection in the field of optical genome mapping is weakening due to a lack of funds for the promotion of Saphyr. However, global equipment shipments to various countries are reducing dependence on local budgets. Bionano Genomics, Inc. (BNGO) generates revenue based on support from oncology centers and the detection of rare pathologies. The cash per share metric demonstrates financial stability, where 0.61 serves as the base value of the parameter.

Cash Funds per Share: Bionano Genomics (BNGO) for 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Bionano Genomics (BNGO)

- cash and cash flow data:
Comprehensive company analysis:Bionano Genomics BNGO
Flagship merchandise of bionanogenomics.com

This multiple serves as a critical filter when assessing an asset's financial stability. The trend in cash per share reflects the volume of liquid reserves available to cover operating expenses. For Bionano Genomics, Inc. (BNGO), this metric determines the business's survival horizon before reaching profitability. Amid reputational pressure from investors, cash acts as the sole guarantor for realizing the potential of the Saphyr system. A rapid depletion of balances signals rising bankruptcy risks.

Key competitors

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology